1. Home
  2. ORMP vs MBOT Comparison

ORMP vs MBOT Comparison

Compare ORMP & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

HOLD

Current Price

$4.10

Market Cap

141.3M

Sector

Health Care

ML Signal

HOLD

Logo Microbot Medical Inc.

MBOT

Microbot Medical Inc.

HOLD

Current Price

$1.72

Market Cap

166.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORMP
MBOT
Founded
2002
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.3M
166.6M
IPO Year
2010
2000

Fundamental Metrics

Financial Performance
Metric
ORMP
MBOT
Price
$4.10
$1.72
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.50
AVG Volume (30 Days)
181.1K
1.5M
Earning Date
05-14-2026
05-15-2026
Dividend Yield
6.51%
N/A
EPS Growth
412.50
60.27
EPS
0.91
N/A
Revenue
$2,000,000.00
$116,887.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$119.77
P/E Ratio
$2.92
N/A
Revenue Growth
49.25
N/A
52 Week Low
$1.98
$1.60
52 Week High
$5.01
$4.62

Technical Indicators

Market Signals
Indicator
ORMP
MBOT
Relative Strength Index (RSI) 46.47 27.71
Support Level $3.83 $1.65
Resistance Level $4.22 $2.23
Average True Range (ATR) 0.29 0.12
MACD -0.04 -0.03
Stochastic Oscillator 13.56 7.63

Price Performance

Historical Comparison
ORMP
MBOT

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

Share on Social Networks: